Save Search
Save your searches to access them later
Saved Searches
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Reset All
Filter Icon Filter 1
Search Paper
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Reset All
Filter Icon Filter 1
Export
Sort by: Relevance
  • Research Article
  • 10.1358/dof.2023.48.3.3560011
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022
  • Mar 1, 2023
  • Drugs of the Future
  • Glenda Walker + 1 more

  • Research Article
  • 10.1358/dof.2023.48.3.3560010
Pipeline on the Move
  • Mar 1, 2023
  • Drugs of the Future
  • Laura Fernández BertolĂ­n

  • Research Article
  • 10.1358/dof.2023.48.3.3500035
Spesolimab. Anti-IL-36R monoclonal antibody, Treatment of generalized pustular psoriasis, Treatment of immune-mediated inflammatory diseases
  • Mar 1, 2023
  • Drugs of the Future
  • Valdemar W Nielsen + 3 more

  • Research Article
  • Cite Count Icon 4
  • 10.1358/dof.2023.48.3.3567668
Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022
  • Mar 1, 2023
  • Drugs of the Future
  • Pamela Brown + 3 more

  • Research Article
  • 10.1358/dof.2023.48.3.3521861
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity
  • Mar 1, 2023
  • Drugs of the Future
  • Thomas L Jensen + 4 more

  • Research Article
  • Cite Count Icon 1
  • 10.1358/dof.2023.48.3.3509749
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma
  • Mar 1, 2023
  • Drugs of the Future
  • Chiara Tarantelli + 1 more

  • Research Article
  • Cite Count Icon 1
  • 10.1358/dof.2023.48.3.3474539
Tinlarebant. Retinol-binding protein 4 (RBP4) inhibitor, Treatment of Stargardt disease, Treatment of dry age-related macular degeneration
  • Mar 1, 2023
  • Drugs of the Future
  • Sabrina Vaccaro + 8 more

  • Research Article
  • 10.1358/dof.2023.48.2.3400571
Ancremonam. Monobactam, Treatment of multidrug-resistant Enterobacteriaceae infections
  • Feb 1, 2023
  • Drugs of the Future
  • Mohammad N Ahmad + 2 more

  • Research Article
  • 10.1358/dof.2023.48.2.3521855
The Liver Meeting 2022 - American Association for the Study of Liver Diseases (AASLD). 73rd Annual Meeting. Washington, D.C. - November 4-8, 2022
  • Feb 1, 2023
  • Drugs of the Future
  • Jaime Gavazzi

  • Research Article
  • Cite Count Icon 1
  • 10.1358/dof.2023.48.2.3474537
Pozelimab/cemdisiran. Complement protein C5 inhibitor, Treatment of complement-mediated diseases
  • Feb 1, 2023
  • Drugs of the Future
  • Morag Griffin